Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Biron

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de MoelleM André, M Henry-Amar, J L Pico, et al.
Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trialJ-P Lotz, B Bui, F Gomez, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centresJ L Lagrange, A Ramaioli, C H Theodore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working PartyI El-Najjar, A Boumendil, J J Luan, et al.
Journal of Geriatric Oncology|June 28, 2015
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective studyE Hermet, A Cabrespine, R Guièze, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de MoelleM André, M Henry-Amar, J L Pico, et al.
Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trialJ-P Lotz, B Bui, F Gomez, et al.
Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centresJ L Lagrange, A Ramaioli, C H Theodore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working PartyI El-Najjar, A Boumendil, J J Luan, et al.
Journal of Geriatric Oncology|June 28, 2015
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective studyE Hermet, A Cabrespine, R Guièze, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Pageof 27